Cross-fostering inhalation toxicity study with HCFC-123 in lactating Sprague-Dawley rats.
A study was performed in Sprague-Dawley rats (Crl:CD BR) to differentiate between effects of hydrofluorocarbon 123 (HCFC-123) on the lactating dam or on the fetus using fostering and cross-fostering of the offspring. Pregnant and/or lactating dams without the pups present were exposed to the test substance (1000 ppm) or clean air by whole-body inhalation for 6 h/day from day 6 to 19 post conceptionem (p.c.) and from day 5 to 21 post partum (p.p.). Pups were cross-fostered to new dams within the first 2 days after birth. Treatment of the mothers with HCFC-123 led to decreases in serum glucose, cholesterol, and triglycerides and increases in absolute and relative maternal liver weights. Decreased litter and individual pup weight and decreased serum triglycerides were observed in the pups of treated foster mothers. Treatment of the mothers with HCFC-123 did not influence milk production based on the body weight difference of the dam before suckling and 60 min after beginning of suckling using 12-pup "standard litters" of untreated dams. Total fat, glucose, and protein contents in the milk were also not influenced by the treatment. Trifluoroacetic acid (TFA), a main metabolite of HCFC-123, was observed in urine samples of standard litters that had been nursed by treated dams. In conclusion, the effects on offspring due to HCFC-123 treatment consisted of decreased pup weight and decreased serum triglycerides at weaning. All effects were due to treatment of the lactating dams, as no prenatally induced effects were found. Since milk production and nutritional constituents of the milk were not influenced, but significant amounts of the main metabolite were found in pup urine, an effect of HCFC-123 or its metabolite on the pups via maternal milk is considered to be a possible cause for their decreased weight gain.
Buschmann
J
J
Fraunhofer Institute of Toxicology and Aerosol Research, Nikolai-Fuchs-Strasse 1, D - 30625 Hannover, Germany. buschmann@ita.fhg.de
Bartsch
W
W
Dasenbrock
C
C
Fuhst
R
R
Pohlmann
G
G
Preiss
A
A
Berger-Preiss
E
E
D000280:Administration, Inhalation; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D017402:Chlorofluorocarbons / Q000493:pharmacokinetics / Q000633:toxicity*; D064227:Chlorofluorocarbons, Ethane; D002849:Chromatography, Gas; D004435:Eating / Q000187:drug effects; D005260:Female; D006706:Homeostasis / Q000187:drug effects; D007774:Lactation / Q000187:drug effects*; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008892:Milk / Q000737:chemistry; D009752:Nutritional Status; D009753:Nutritive Value; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D016019:Survival Analysis
D017402:Chlorofluorocarbons; D064227:Chlorofluorocarbons, Ethane; C067411:2,2-dichloro-1,1,1-trifluoroethane